Redmile Group

Strand Therapeutics Chief Operating Officer Samta Kundu CEO and co-founder Jake Becraft and President Head of RD and co-fo
Biotech

Strand snags $52M to develop next-gen mRNA meds for cancer

Strand, a company working on mRNA-based treatments, raised $52 million to get its first cancer immunotherapy into the clinic.
Amirah Al Idrus Jun 23, 2021 8:00am
dollar sign money

Entrada raises $116M to take DMD therapy into the clinic

Mar 31, 2021 8:55am
AgomAb

AgomAb raises $74M to develop regenerative pathway modulators

Mar 10, 2021 5:00am